$ABSI News

Is Absci (ABSI) Undervalued As Positive ABS 201 Phase 1 Data Lifts Optimism?

Absci (ABSI) Stock Seems Rich Against Its Book Value Backdrop

Keybanc Maintains Overweight on Absci, Raises Price Target to $20

Absci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026

HC Wainwright & Co. Reiterates Buy on Absci, Maintains $16 Price Target

Absci (ABSI) Stock Dropped, So What Is Behind The Latest Attention?

Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis

Needham Reiterates Buy on Absci, Maintains $11 Price Target

Absci (ABSI) Stock Looks Expensive Against Its Book Value

Absci Corporation (ABSI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Baldness Drug Stocks like Veradermics (MANE) and Absci (ABSI) Are Chasing the Same Wall Street Magic as Ozempic

Absci: Positive Ph1 Data ABS-201 AGA And Several Catalysts Inbound (Upgrade)

BTIG Maintains Buy on Absci, Raises Price Target to $16

Absci to Participate in Upcoming Investor Conferences

Absci (ABSI) Q2 2026 Earnings Call Transcript

Needham Reiterates Buy on Absci, Maintains $11 Price Target

BTIG Reiterates Buy on Absci, Maintains $13 Price Target

Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results

Absci Corporation (ABSI) Q2 2026 Earnings Call Transcript

Absci Q2 EPS $(0.21) Misses $(0.20) Estimate, Sales $318.000K Miss $1.169M Estimate